If you notice text formatting issues, please update your browser to view the website correctly
.
See More
If you notice text formatting issues, please update your browser to view the website correctly
.
See MoreIf you notice text formatting issues, please update your browser to view the website correctly
.
This page has been recently translated and is available in French now.
Looks like you're visiting us from {countryName}.
Would you like to stay on the current location site or be switched to your location?
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Expression of TNF by stimulated human peripheral blood mononuclear cells (PBMC). Human PBMC were stimulated for 4 hrs with PMA (5 ng/ml, Sigma) and Ionomycin (500 ng, Sigma) in the presence of Brefeldin A (Cat. No. 555029). Cells were harvested, fixed, permeabilized and stained with PE mouse anti-human CD8 (Cat. No. 555367) and either PE-Cy7 mouse anti-human TNF antibody (Cat. No.557647/560923/560678, left panel) or PE-Cy™7 Mouse IgG1 κ Isotype Control (Cat. No. 557646, right panel). To demonstrate specificity of staining, the binding of PE-Cy™7 Mouse Anti-Human TNF was blocked by the preincubation of the conjugated antibody with molar excess of recombinant human TNF (0.25 µg,Cat. No. 554618) and the fixed/permeabilized cells with an excess of Purified Mouse Anti-Human TNF (5 µg, Cat. No. 554510) (data not shown) prior to staining. Quadrant markers were set based on the autofluorescence and isotype controls.
Any use of products other than the permitted use without the express written authorization of Becton, Dickinson and Company is strictly prohibited.
Immunofluorescent Staining and Flow Cytometric Analysis: The MAb11 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify and enumerate TNF producing cells within mixed cell populations. The FITC-, PE-, APC-, and PE-Cy7-conjugated MAb11 antibodies (Cat. No. 554512, 554513 , 554514, and557647, respectively) are especially suitable for these studies (see image). For optimal immunofluorescent staining with flow cytometric analysis, this anti-cytokine antibody should be used at 5 µl/test The staining technique and use of blocking controls are described in detail by C. Prussin and D. Metcalfe.3 For specific methodology, please visit our website, http://www.bdbiosciences.com/us/s/resources, and go to the protocols section under "Cytokines (Intracellular Staining)" or "Intracellular Flow".
ELISA Detection: The biotinylated MAb11 antibody (Cat. No. 554511) can be used as the detection antibody in a sandwich ELISA for measuring human TNF protein levels in conjunction with clone MAb1 (Cat. No. 551220; purified mouse anti-human TNF) as the capture antibody and recombinant human TNF (Cat. No. 554618) as the standard. For specific methodology, please visit the protocols section under "ELISA and ELISPOT" at our website, http://www.bdbiosciences.com/us/s/resources.
The MAb11 monoclonal antibody specifically binds to human tumor necrosis factor (TNF, also known as TNF-α) protein. TNF is an efficient juxtacrine, paracrine and endocrine mediator of inflammatory and immune functions. It regulates the growth and differentiation of a variety of cell types. TNF is cytotoxic for transformed cells when in conjunction with IFN-γ. It is secreted by activated monocytes/macrophages and other cells such as B cells, T cells and fibroblasts. The immunogen used to generate the MAb11 hybridoma was recombinant human TNF. The MAb11 antibody has been reported to crossreact with Rhesus Macaque TNF.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.